Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: A Future of Doubt: For Diabetes Sufferers, History Forces us to Question the Fut
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Actually, the author appears to have an agenda.

"Furthermore, Afrezza wasn’t the only diabetic medication whose market potential was rightfully stunted by the FDA in the last year."

Rightfully stunted by the FDA???

Let's see:

Avandia - associated with heart attack, stroke, death

Actos - bladder cancer

dapagliflozin - breast cancer, bladder cancer

Afrezza - ????

Of course did anyone notice that the author is a lawyer and his blog is called "Injury Board"?

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply